Shares of Sun Pharmaceutical Industries rose nearly 2 per cent on the Bombay Stock Exchange amid media reports that the US FDA has upgraded current status of the company’s Halol plant to VAI (Voluntary Action Indicated).
The company in a clarification to exchange said that we are awaiting the receipt of the Establishment Inspection Report (EIR) from the US FDA for the above referred GMP inspection conducted at our Halol facility from February 12-23, 2018. As and when we receive the EIR, we shall inform the exchanges immediately.
Extending previous session rally, stocks of the company gained as much as 1.66 per cent and touched an intra-day high of Rs 543.90 apiece on the Bombay Stock Exchange.
In a similar trend, shares of the firm were trading 1.36 per cent higher at Rs 543.00 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 35,689.34, up 205.87 points, or 0.58 per cent at 12:24 hours.